Literature DB >> 9436809

Effect of taurine on angiotensin II-induced hypertrophy of neonatal rat cardiac cells.

K Takahashi1, M Azuma, K Taira, A Baba, I Yamamoto, S W Schaffer, J Azuma.   

Abstract

The effect of taurine on angiotensin II-induced hypertrophy of cultured neonatal rat heart cells (myocytes and nonmyocytes) was examined. Angiotensin II (1-100 nM) alone caused an increase in the rate of protein synthesis of myocytes without changing the rate of DNA synthesis and cell number. It mediated increases in DNA synthesis and cell number in nonmyocytes. Furthermore, at the lower concentration of 1 nM, it induced c-fos and c-jun expression in both cultured myocytes and nonmyocytes. Exposure of the cells to taurine (20 mM) in the absence of angiotensin II had no effect on either hyperplastic growth or immediate early response gene expression by the two types of cultured cardiac cells. However, myocytes pretreated for 24 h with 20 mM taurine exhibited reduced responsiveness to angiotensin II (1 nM), resulting in lower levels of angiotensin II-mediated stimulation in protein synthesis, and immediate early response gene expression was attenuated. Similarly, taurine treatment of nonmyocytes reduced the degree of hyperplastic growth (DNA synthesis and cell number) and immediate early response gene expression stimulated by angiotensin II. Finally, taurine partially prevented the increase in intracellular free calcium [Ca2+]i mediated by angiotensin II in cardiac cells. Our results indicate that taurine is an effective inhibitor of angiotensin II action.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9436809     DOI: 10.1097/00005344-199712000-00004

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  6 in total

1.  Angiotensin II stimulates hyperplasia but not hypertrophy in immature ovine cardiomyocytes.

Authors:  N C Sundgren; G D Giraud; P J S Stork; J G Maylie; K L Thornburg
Journal:  J Physiol       Date:  2003-03-07       Impact factor: 5.182

2.  The potential health benefits of taurine in cardiovascular disease.

Authors:  Yan-Jun Xu; Amarjit S Arneja; Paramjit S Tappia; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2008

3.  Taurine, an osteocyte metabolite, protects against oxidative stress-induced cell death and decreases inhibitors of the Wnt/β-catenin signaling pathway.

Authors:  M Prideaux; Y Kitase; M Kimble; T M O'Connell; L F Bonewald
Journal:  Bone       Date:  2020-04-21       Impact factor: 4.398

Review 4.  Dietary Thiols: A Potential Supporting Strategy against Oxidative Stress in Heart Failure and Muscular Damage during Sports Activity.

Authors:  Mariarita Brancaccio; Cristina Mennitti; Arturo Cesaro; Fabio Fimiani; Elisabetta Moscarella; Martina Caiazza; Felice Gragnano; Annaluisa Ranieri; Giovanni D'Alicandro; Nadia Tinto; Cristina Mazzaccara; Barbara Lombardo; Raffaela Pero; Giuseppe Limongelli; Giulia Frisso; Paolo Calabrò; Olga Scudiero
Journal:  Int J Environ Res Public Health       Date:  2020-12-16       Impact factor: 3.390

5.  Shexiang Tongxin Dropping Pill Protects Against Chronic Heart Failure in Mice via Inhibiting the ERK/MAPK and TGF-β Signaling Pathways.

Authors:  Shuying Zhang; Hanbing Liu; Qianqian Fang; Houhong He; Xiaoyan Lu; Yi Wang; Xiaohui Fan
Journal:  Front Pharmacol       Date:  2021-12-03       Impact factor: 5.810

Review 6.  The Anti-Inflammatory Effect of Taurine on Cardiovascular Disease.

Authors:  Tawar Qaradakhi; Laura Kate Gadanec; Kristen Renee McSweeney; Jemma Rose Abraham; Vasso Apostolopoulos; Anthony Zulli
Journal:  Nutrients       Date:  2020-09-17       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.